Close

[UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION

Go back to [UPDATED] CURATIVE BIOTECHNOLOGY ANNOUNCES OCULAR TOLERANCE EVALUATION OF METFORMIN EYE DROP FORMULATIONS FOR TREATMENT OF MACULAR DEGENERATION
(AMEX: CUBT) Delayed: 0.03 --0 (-0%)
Previous Close $0.03    52 Week High
Open $0.03    52 Week Low
Day High $0.03    P/E N/A 
Day Low $0.03    EPS
Volume 10,700